I No Longer Think GLP-1s Are the Answer
By Christopher McGowan, MD An original Op-Med article contributed by Doximity members. Few medications have had such a meteoric rise as semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound), the GLP-1-based treatments for obesity that have captivated society and quickly become household names. These drugs represent a significant advancement in obesity medicine — for a good reason. […]